News and Events

In the News

CoreLab Partners to Showcase Cardiac Safety Expertise at Industry Conferences
May 17, 2010

CoreLab Partners, Inc, the recently established global entity resulting from the merger between RadPharm and Medifacts International, will chair key sessions during leading industry conferences in May. Boaz Mendzelevski, MD, Vice President of Cardiology, CoreLab Partners, will Chair the programs of the MACTO Cardiovascular Safety Workshop and the 1st DIA Cardiac Safety Workshop in Japan. Additionally, Dr. Mendzelevski will Chair a stream during the Exploratory Clinical Development World – Europe 2010 Conference.

CoreLab Partners Launches New Brand Identity
April 12, 2010

CoreLab Partners, Inc, the recently established global entity resulting from the merger between RadPharm and Medifacts International, has launched a new brand identity to reinforce their capabilities as one of the largest imaging sciences and cardiac safety core labs in the market today.

RadPharm, Inc. a leading Imaging Core Laboratory and Medifacts International, Inc, a leading Cardiovascular Core Laboratory today announced the merger of their business operations. The combined company will be named CoreLab Partners (“CoreLabs”) and will have its corporate headquarters in Princeton, New Jersey.

RadPharm, Medifacts to Become CoreLab Partners
CWWeekly, February 2010

Core laboratories Rad-Pharm and Medifacts International recently merged business operations, hoping to attract new clients with their combined portfolios.

RadPharm Inc, a global provider of centralized medical image management services to the Biopharmaceutical and medical device industries, was recognized as the third-ranked company among the fifty nominated as one of "New Jersey’s Finest” in 2009.

RadPharm Supports Komen Race for the Cure
October 22, 2009

RadPharm Inc., a global imaging core lab with extensive experience in Oncology drug development, is pleased to pledge its continued support for the Susan G. Komen Race for The Cure.

RadPharm Inc, a global provider of centralized medical image management services to the bio-pharmaceutical and medical device industries announced today that two key executives will be presenting during the upcoming 4th Phacilitate Oncology Leaders Forum 2009 to be held November 9-11, 2009, in Boston, MA. The conference, to be co-located with the Phacilitate 14th R&D Leaders Forum 2009, brings together senior level R&D and business development executives driving the development and launch of novel cancer therapeutics of all classes.

RadPharm Inc., is pleased to announce the publication of an abstract and the release of two abstracts to be presented during oral presentations at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, which is being held in Orlando, FL from May 30-June 1, 2009.

RadPharm Inc, a leading global provider of centralized medical imaging review services to biotechnology, pharmaceutical and medical device organizations is pleased to announce that their Founder and Chief Medical Officer, Robert Ford, M.D, is a contributing author to five articles which were included in the special RECIST 1.1 issue of the European Journal of Cancer.

RadPharm Inc, a leading Imaging CRO, has announced the appointment of Steven F. Owens to the position of Chief Information Officer. In this newly created role, Mr. Owens will serve on the executive committee and provide leadership to IT and development projects that enhance technical capabilities and strengthen business processes critical to delivering outstanding service to RadPharm clients.

RadPharm Inc., a leading imaging CRO, today announced that CEO, Ronald A. Berg, is a finalist for The New Jersey Ernst & Young Entrepreneur Of The Year® 2008 Awards. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities. Mr. Berg was selected as a finalist from over 50 nominations by a panel of independent judges. Award winners will be announced at a special gala event on Thursday June 19th, 2008 at the Marriott Teaneck at Glenpointe, Teaneck, New Jersey.

RadPharm, Inc., a leading provider of medical image review services for clinical research, announced the completion of a $10 million Series B financing led by Siemens Venture Capital (“SVC”). Existing investors Ampersand Ventures, Adams Street Partners and Tang Capital Management participated in the financing.


	Home \| About Us \| Contact Us \| Site Index \| Privacy Policy	Copyright 2009 RadPharm Inc. All rights reserved.